Other possible causes that might mediate the improvement of renal injury in DN rat treated with MSCs may be related to the declined levels of IL1β, IL6, TNF‐α and MCP‐1, which played an important role in the activation and infiltration of inflammatory cells in diseased kidney. This evidence concerns the gene IL6 and liver dysplastic nodule.